Non-Invasive Prenatal Test NIPT Test in Cyprus
What Is the NIPT Test?
The NIPT Test (Non-Invasive Prenatal Test) is an advanced prenatal screening method used during pregnancy to detect certain chromosomal abnormalities in the baby.
This test analyzes small fragments of fetal DNA, known as cell-free fetal DNA (cffDNA), that circulate in the mother’s bloodstream. By examining these DNA fragments, the NIPT Test can screen for several genetic conditions without the need for invasive procedures.
The test can be safely performed from the 10th week of pregnancy and requires only a simple blood sample from the mother.
At Dogus IVF Center in Cyprus, the NIPT Test is offered as part of comprehensive prenatal care to support the health of both mother and baby.
How Is the NIPT Test Performed?
The procedure is simple and completely safe for both mother and baby.
1. Blood Sample Collection
A small blood sample is taken from the expectant mother.
2. Laboratory Analysis
The sample is analyzed in specialized genetic laboratories using advanced sequencing technologies.
3. Fetal DNA Isolation
Cell-free fetal DNA is isolated from the maternal blood sample.
4. Chromosomal Screening
Genetic analysis is performed to screen for specific chromosomal abnormalities.
Because the NIPT Test only requires a blood sample, it carries no risk of miscarriage, unlike invasive procedures such as amniocentesis or chorionic villus sampling (CVS).
What Conditions Can the NIPT Test Detect?
The NIPT Test can screen for several common chromosomal abnormalities, including:
- Trisomy 21 (Down Syndrome)
- Trisomy 18 (Edwards Syndrome)
- Trisomy 13 (Patau Syndrome)
- Sex chromosome abnormalities
Depending on the testing panel selected, additional screening may include:
- Microdeletion syndromes
- Microduplication syndromes
Expanded testing panels allow broader genetic screening when medically appropriate.
Who Should Consider the NIPT Test?
Although the NIPT Test can be performed in most pregnancies, it is particularly recommended in certain situations:
- Pregnancy at age 35 or older
- Pregnancies achieved through IVF or ICSI treatment
- Abnormal results in first-trimester screening tests
- Previous pregnancy with a chromosomal abnormality
- Suspicious findings during ultrasound examination
- Twin pregnancies (in many cases)
- Patients who prefer to avoid invasive diagnostic tests
A fertility specialist or obstetrician will evaluate the patient’s medical history before recommending prenatal screening options.
Advantages of the NIPT Test
High Accuracy
The NIPT Test is one of the most reliable prenatal screening methods available today, with accuracy rates approaching 99% for certain chromosomal conditions.
Safe for Mother and Baby
The test requires only a blood sample, meaning no risk of miscarriage.
Early Detection
Screening can be performed from the 10th week of pregnancy, allowing early evaluation of potential chromosomal abnormalities.
Early Gender Determination
Because fetal DNA is analyzed, the baby’s gender can often be determined early in pregnancy with high accuracy.
NIPT Testing Process
The testing process generally includes the following steps:
- Blood sample collection from the expectant mother
- Isolation of fetal DNA in a specialized laboratory
- Chromosomal screening analysis
- Test results usually available within 3–10 days
- Results reviewed and explained by fertility or genetic specialists
How Are NIPT Test Results Interpreted?
The NIPT Test is considered a screening test, not a definitive diagnostic test.
Results are typically reported in two categories:
Low Risk
The likelihood of the screened chromosomal conditions is very low, and routine pregnancy monitoring continues.
High Risk
If an increased risk is detected, confirmatory diagnostic tests such as amniocentesis or CVS may be recommended.
Genetic counseling may also be provided to help patients understand the results.
NIPT Test at Dogus IVF Center
At Dogus IVF Center Cyprus, the NIPT Test is offered as part of modern prenatal screening services.
Our specialists evaluate each patient individually and provide detailed guidance regarding genetic screening and follow-up care during pregnancy.
The goal is to combine advanced genetic technologies with personalized medical care to support healthy pregnancies.
